In particular, CRT exposed on tumor cells undergoing ICD are phagocyted by immature DCs, that migrating to the lymph nodes cross-present to CD8+ T cells eliciting a strong anti-tumor activity. The gene discussed is CD8A; the disease is neoplasm.